Clinical Study of Z-213 in Subjects With Iron-deficiency Anemia
Phase of Trial: Phase III
Latest Information Update: 09 Mar 2018
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Iron deficiency anaemia
- Focus Adverse reactions; Registrational
- Sponsors Zeria
- 04 Mar 2018 Status changed from active, no longer recruiting to completed.
- 24 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 15 Jul 2016 New trial record